Diuretic Therapy in End-Stage Renal Disease (ESRD) Patients

Introduction to Diuretic Therapy in ESRD

The American Society of Nephrology notes that in ESRD patients with GFR <15 ml/min/1.73m², furosemide has significantly reduced efficacy due to minimal functioning nephrons, reduced delivery of the drug to its site of action, and uremic toxins competing for protein binding sites 1, 2
Clinical guidelines specifically note that diuretic therapy should be withheld in renal failure defined as dialysis dependence, oliguria with serum creatinine >3 mg/dL, or oliguria with urinary indices indicative of acute renal failure, as stated by the Intensive Care Medicine society 1

The Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommends assessing for residual renal function, as furosemide may have some limited effect in patients with documented residual urine output (>100-200 ml/day) 1, 2
Consider the clinical indication for furosemide use, such as volume overload between dialysis sessions, pulmonary edema requiring urgent intervention, or hyperkalemia management (limited effect), as suggested by the American Journal of Kidney Diseases society 2

Evaluate the risk-benefit ratio of furosemide use, considering the potential benefit of modest increase in urine output if residual function exists, and potential risks of electrolyte disturbances and ototoxicity with high doses, as noted by the Intensive Care Medicine society 1
Be aware of the potential for overestimating efficacy, as even a 20mg dose will have minimal effect in ESRD patients with GFR 7, and dose escalation is unlikely to provide proportionally greater benefit but increases risk of side effects, as stated by the American Journal of Kidney Diseases society 2

Optimize dialysis prescription (ultrafiltration goals), strict fluid restriction between dialysis sessions, dietary sodium restriction, and consider more frequent dialysis sessions if volume overload is recurrent, as recommended by the American Society of Nephrology 1, 2
Relying solely on diuretics is not recommended, as dialysis remains the primary method for volume control in ESRD patients, as noted by the Intensive Care Medicine society 1